Suppr超能文献

女性因素:预测前列腺癌根治术后勃起功能保留计划的依从性。

The female factor: predicting compliance with a post-prostatectomy erectile preservation program.

机构信息

Baylor College of Medicine-Scott Department of Urology, Houston, TX, USA.

出版信息

J Sex Med. 2010 Nov;7(11):3659-65. doi: 10.1111/j.1743-6109.2010.02014.x. Epub 2010 Aug 31.

Abstract

INTRODUCTION

Early post-radical prostatectomy (RP) erectile preservation (EP) therapy may be critical to preserve erections after surgery.

AIM

To assess if pre-RP female sexual function predicts of partner compliance with an EP protocol.

MAIN OUTCOME MEASURES

Compliance, defined as use of localized penile EP therapy (intracavernosal injections [ICIs], vacuum erection device [VED], or alprostadil) at 3 and 6 months after RP.

METHODS

Records of patients enrolled in our EP program from April 2007 to June 2008 were reviewed. Before surgery, patients completed the Sexual Health Inventory for Men (SHIM) and their female partners completed the Female Sexual Function Index (FSFI) questionnaire. Prior to surgery, patients were advised to take sildenafil 25 mg every nightly and use a 250-µg alprostadil suppository three times/week. At 1 month, additional daily use of a VED was encouraged. All patients unable to achieve erections sufficient for penetration were encouraged to initiate ICI of Trimix (phentolamine, papaverine, and PGE1) twice weekly after 3 months following surgery. Data were analyzed using binary logistic regression analysis holding all input variables constant.

RESULTS

Twenty-nine patients had preoperative SHIM>7 and pre-RP partner FSFI data available. After a 4-week follow-up, compliance with alprostadil suppository declined and both ICI and VED usage increased. At 6 months, six (25.0%) patients had return of natural erectile function and 22 (91.7%) were achieving assisted erections. Higher preoperative partner FSFI scores were associated with greater compliance to the localized penile therapy component of our EP protocol (risk ratio 3.8, P=0.05).

CONCLUSIONS

Preoperative female sexual function correlated with greater partner compliance with the localized component of our EP protocol. Consideration of a female partner's preoperative sexual function in predicting patient erectile function recovery after RP is warranted. Future studies are necessary to determine the clinical significance of this factor.

摘要

介绍

根治性前列腺切除术(RP)后早期的勃起功能保护(EP)治疗对术后保持勃起功能可能至关重要。

目的

评估 RP 前女性性功能是否能预测伴侣对 EP 方案的依从性。

主要观察指标

依从性,定义为在 RP 后 3 个月和 6 个月时使用局部阴茎 EP 治疗(阴茎内注射[ICI]、真空勃起装置[VED]或前列腺素 E1])。

方法

回顾了 2007 年 4 月至 2008 年 6 月期间参加 EP 计划的患者记录。在手术前,患者完成了男性性健康问卷(SHIM),他们的女性伴侣完成了女性性功能指数(FSFI)问卷。在手术前,患者被建议每晚服用 25 毫克西地那非,并每周使用 250 微克前列腺素 E1 栓剂 3 次。在 1 个月时,鼓励每天额外使用 VED。所有无法获得足够勃起以进行插入的患者在手术后 3 个月后被鼓励开始每周两次注射二联混合物(酚妥拉明、罂粟碱和 PGE1)。使用二元逻辑回归分析保持所有输入变量不变,对数据进行分析。

结果

29 名患者有术前 SHIM>7 和 RP 前伴侣 FSFI 数据。经过 4 周的随访,前列腺素 E1 栓剂的依从性下降,ICI 和 VED 的使用率增加。在 6 个月时,6 名(25.0%)患者自然勃起功能恢复,22 名(91.7%)患者实现了辅助勃起。术前伴侣 FSFI 评分较高与对我们 EP 方案的局部阴茎治疗部分的依从性较高相关(风险比 3.8,P=0.05)。

结论

术前女性性功能与伴侣对我们 EP 方案的局部治疗成分的依从性较高相关。在预测 RP 后患者勃起功能恢复时,考虑女性伴侣的术前性功能是合理的。需要进一步的研究来确定这一因素的临床意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验